Petrus Jacobus Johannes Antonius BUIJNSTERS,Henricus Jacobus Maria GIJSEN,Wilhelmus Helena Ignatius Maria DRINKENBURG,Abdallah AHNAOU
申请号：
US15772859
公开号：
US20180327408A1
申请日:
2016.11.02
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to a novel [1,2,4]triazolo[1,5-a]pyrimidin-yl derivative as inhibitor of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compound, to processes for preparing such compound and compositions, and to the use of such compound and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorder.
